Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.320
+0.090 (7.32%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Biomea Fusion Employees
Biomea Fusion had 40 employees as of March 31, 2026. The number of employees decreased by 1 or -2.44% since the number was last reported on December 31, 2025.
Employees
40
Change
-1
Growth
-2.44%
Revenue / Employee
n/a
Profits / Employee
-$1,123,750
Market Cap
95.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Inovio Pharmaceuticals | 112 |
| PolyPid | 75 |
| ImmuCell | 73 |
| Rani Therapeutics Holdings | 71 |
| NeurAxis | 24 |
| Atara Biotherapeutics | 13 |
| ProMIS Neurosciences | 11 |
BMEA News
- 17 days ago - Biomea Fusion Transcript: AGM 2026 - Transcripts
- 22 days ago - Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study - GlobeNewsWire
- 23 days ago - Biomea Fusion management to meet with Citizens - TheFly
- 23 days ago - Biomea Fusion Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Biomea Fusion partners with University of Leicester on obesity study - TheFly
- 24 days ago - Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity - GlobeNewsWire
- 4 weeks ago - Biomea Fusion Slides: Corporate presentation - Filings
- 5 weeks ago - Biomea Fusion Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts